查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1719247

烟碱酰胺市场－全球产业规模、份额、趋势、机会及预测（按销售管道、最终用途、地区和竞争细分，2020-2030 年）

Nicotinamide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球烟碱酰胺市场价值为 6.2474 亿美元，预计到 2030 年将达到 10.9534 亿美元，复合年增长率为 6.61%。烟碱酰胺，也称为烟碱酰胺，是维生素 B3 的水溶性形式，在代谢功能和细胞修復中发挥着至关重要的作用。它在药品、食品和化妆品领域的广泛适用性使其成为各种消费者健康和保健领域的关键成分。人们越来越意识到它在皮肤护理、发炎控制和代谢健康方面的益处，这推动了它在治疗和生活方式相关应用中的采用。新兴市场对健康和个人护理支出的需求不断增加，进一步推动了烟碱酰胺市场的上升趋势。然而，如果不有效解决原材料依赖和监管审查等挑战，可能会影响长期成长。

市场概览
预测期 2026-2030
2024年市场规模 6.2474亿美元
2030年市场规模 10.9534亿美元
2025-2030 年复合年增长率 6.61%
成长最快的领域 直接的
最大的市场 亚太地区

关键市场驱动因素

製药业的成长

主要市场挑战

原物料价格波动

主要市场趋势

膳食补充剂行业的成长

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19 对全球烟碱酰胺市场的影响

第五章：全球烟碱酰胺市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按销售管道（直接、间接）
    • 依最终用途（药品、化妆品和个人护理、食品和饮料、动物饲料、化学物质）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美烟碱酰胺市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第七章：欧洲烟碱酰胺市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太烟碱酰胺市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章：南美洲烟碱酰胺市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东和非洲烟碱酰胺市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如有）
  • 最新动态

第 13 章：全球烟碱酰胺市场：SWOT 分析

第 14 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章：竞争格局

  • Nebula Health Care
  • Suchem Laboratory
  • Western Drugs Limited
  • Roopa industries limited
  • SV Labs Pvt. Ltd.
  • Veer Chemie & Aromatics pvt ltd.
  • Optimus Drugs Pvt. Ltd
  • NIGAM FINECHEM PVT. LTD
  • Ishita Drugs & Industries Ltd
  • Anhui Redpont Biotechnology Co., Ltd

第 16 章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 28767

The Global Nicotinamide Market was valued at USD 624.74 million in 2024 and is expected to reach USD 1095.34 million by 2030, growing at a CAGR of 6.61%. Nicotinamide, also known as niacinamide, is a water-soluble form of vitamin B3 that plays a vital role in metabolic function and cellular repair. Its wide applicability across pharmaceutical, dietary, and cosmetic products positions it as a critical ingredient in various consumer health and wellness segments. Growing awareness of its benefits in skin care, inflammation control, and metabolic health is fueling its adoption across both therapeutic and lifestyle-related applications. Increasing demand from emerging markets, where health and personal care spending is on the rise, further contributes to the upward trajectory of the nicotinamide market. However, challenges such as raw material dependency and regulatory scrutiny may impact long-term growth if not effectively addressed.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 624.74 Million
Market Size 2030USD 1095.34 Million
CAGR 2025-20306.61%
Fastest Growing SegmentDirect
Largest MarketAsia Pacific

Key Market Drivers

Growth in Pharmaceutical Industry

The growing demand from the global pharmaceutical industry is a primary driver propelling the nicotinamide market. With the global healthcare sector generating more than USD 4 trillion annually-USD 850 billion from pharmaceuticals and biotechnology alone-nicotinamide's role in therapeutic formulations is expanding rapidly. It is widely used to treat niacin deficiency disorders, support dermatological therapies, and enhance metabolic health. Recent developments, such as Zhejiang University's co-crystallization of Ticagrelor with Nicotinamide to enhance drug solubility, underscore the compound's value in improving pharmaceutical formulations. As global pharmaceutical innovation continues to focus on solubility, efficacy, and patient outcomes, the incorporation of nicotinamide is expected to increase further across prescription and over-the-counter product categories.

Key Market Challenges

Fluctuating Raw Material Prices

Volatility in raw material prices is a key challenge for the nicotinamide market. The compound is primarily synthesized from nicotine, which is extracted from tobacco-a crop subject to variable supply conditions and geopolitical influences. Fluctuations in raw material availability or pricing can disrupt production stability and increase operational costs. These pressures are particularly impactful in regions where raw material sourcing is heavily reliant on imports. Rising sustainability standards and the need for consistent, cost-effective manufacturing practices place additional strain on producers, especially those operating in price-sensitive markets. As a result, manufacturers must continuously monitor and adapt to raw material market dynamics to ensure competitiveness.

Key Market Trends

Growth in the Dietary Supplement Sector

The dietary supplement sector is emerging as a major growth avenue for nicotinamide. With increasing consumer interest in preventive healthcare, wellness, and anti-aging, demand for nicotinamide-based supplements is on the rise. Notably, derivatives like Nicotinamide Riboside (NR), which boosts NAD+ levels in cells, are gaining traction for their potential anti-aging and metabolic benefits. This interest extends beyond general health, with pharmaceutical research exploring NR's applications in areas such as neurological health and energy metabolism. As consumers seek functional ingredients with clinically proven benefits, nicotinamide's presence in the supplement market continues to strengthen, supported by a growing body of scientific evidence and shifting consumer health priorities.

Key Market Players

  • Nebula Health Care
  • Suchem Laboratory
  • Western Drugs Limited
  • Roopa Industries Limited
  • S.V. Labs Pvt. Ltd.
  • Veer Chemie & Aromatics Pvt Ltd.
  • Optimus Drugs Pvt. Ltd
  • NIGAM FINECHEM PVT. LTD
  • Ishita Drugs & Industries Ltd
  • Anhui Redpont Biotechnology Co., Ltd

Report Scope:

In this report, the Global Nicotinamide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nicotinamide Market, By Sales Channel:

  • Direct
  • Indirect

Nicotinamide Market, By End Use:

  • Pharmaceuticals
  • Cosmetics & Personal Care
  • Food & Beverages
  • Animal Feed
  • Chemicals

Nicotinamide Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nicotinamide Market.

Available Customizations:

Global Nicotinamide Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Nicotinamide Market

5. Global Nicotinamide Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Pharmaceuticals, Cosmetics & Personal Care, Food & Beverages, Animal Feed, Chemicals)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Nicotinamide Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Nicotinamide Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Nicotinamide Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Nicotinamide Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Nicotinamide Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Nicotinamide Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Nicotinamide Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Nicotinamide Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Nicotinamide Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Nicotinamide Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Nicotinamide Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Nicotinamide Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Nicotinamide Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Nicotinamide Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Nicotinamide Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Nicotinamide Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Nicotinamide Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Nicotinamide Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Nicotinamide Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Nicotinamide Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Nicotinamide Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Nicotinamide Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Nicotinamide Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Nicotinamide Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Nicotinamide Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Nebula Health Care
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Suchem Laboratory
  • 15.3. Western Drugs Limited
  • 15.4. Roopa industries limited
  • 15.5. S.V. Labs Pvt. Ltd.
  • 15.6. Veer Chemie & Aromatics pvt ltd.
  • 15.7. Optimus Drugs Pvt. Ltd
  • 15.8. NIGAM FINECHEM PVT. LTD
  • 15.9. Ishita Drugs & Industries Ltd
  • 15.10. Anhui Redpont Biotechnology Co., Ltd

16. Strategic Recommendations

17. About Us & Disclaimer